Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chuncheon
Clinical trial register · South Korea

Clinical Trials in Chuncheon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Chuncheon Sacred Heart Hospital6 Seoul National University Hospital5 Seung-Jung Park5 National Cancer Center, Korea2 Pharmicell Co., Ltd.2
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Chuncheon

50 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Not yet open
Chonnam National University Hospital
Not applicable
1,252
Bucheon-si, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu, Daejeon, Gwangju
2026-09-01
Not yet open
Seoul National University Hospital
Not applicable
2,301
Chuncheon, Gangneung, Anyang-si, Bucheon-si, Goyang-si, Changwon, Busan, Daegu
2026-06-15
Recruiting
LEXURE for Post-Stroke Aphasia
NCT07570264Aphasia
Nunaps Inc
Not applicable
116
Ansan, Busan, Chuncheon, Daegu, Gwangju, Ilsan, Jeonju, Seoul
2026-04-16
Recruiting
The DECISION-CTO Extended 10 Y Follow-up
NCT06908499Coronary Artery Disease
Seung-Jung Park
Observational
840
Anyang, Bucheon-si, Busan, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2026-04-01
Not yet open
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
NCT07398001Percutaneous Coronary Intervention, Antiplatelet Therapy, Drug-coated Balloon
Ulsan University Hospital
Not applicable
1,042
Ansan, Chuncheon, Pusan, Seoul, Ulsan
2026-02-12
Recruiting
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
NCT07687706Ischemic Stroke, Ischemic Stroke, Acute, Transient Ischemic Attack (TIA), Cerebrovascular Disease
DrugTegoprazan
Hanyang University Guri Hospital
Phase 3
1,524
Busan, Daegu, Chuncheon, Anyang-si, Iksan, Jeonju, Cheongju-si, Guri-si
2026-01-26
Recruiting
STarting incrEmental Prescription of Peritoneal Dialysis
NCT06642597Peritoneal Dialysis (PD), Kidney Failure
The University of Queensland
Not applicable
224
Chuncheon, Daegu
2025-09-19
Recruiting
Pfizer
Phase 3
6,000
Chuncheon, Gwangju, Seoul, Daegu
2025-08-25
Recruiting
Jung-min Ahn
Phase 4
5,000
Anyang, Bucheon-si, Busan, Changwon, Cheonju, Chuncheon, Daegu, Daejeon
2025-07-24
By invitation
Effect of Daily Chlorhexidine Bathing and Antibiotic/PPI Stewardship on Prevention of CPE Transmission and Infection
NCT07039955Carbapenemase-Producing Enterobacteriaceae (CPE), Healthcare-Associated Infections (HAIs)
Chuncheon Sacred Heart Hospital
Not applicable
5,760
Chuncheon, Gangneung, Wŏnju
2025-07-14
Recruiting
Incheon St.Mary's Hospital
Phase 4
160
Ansan, Busan, Chilgok, Chuncheon, Gwangju, Incheon, Seoul, Yangsan
2025-07-07
Recruiting
AstraZeneca
Phase 2
987
Anyang-si, Cheongju-si, Chuncheon, Daegu, Jeonju, Seongnam-si, Seoul, Wŏnju
2025-06-27
Not yet open
Scapular Dyskinesis With Impingement Syndrome
NCT07001228Scapular Dyskinesis, Impingement Syndrome, Shoulder
Chuncheon Sacred Heart Hospital
Not applicable
360
Chuncheon
2025-05-29
Recruiting
ISB With SSNB & ANB
NCT06878391Rotator Cuff Tear
Chuncheon Sacred Heart Hospital
Not applicable
100
Chuncheon
2025-03-24
Recruiting
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
NCT06649240Ischemic Stroke, Small Vessel Cerebrovascular Disease, Cholesterol, LDL, Secondary Prevention
DrugsBiweekly·Ezetimibe
Seoul National University Hospital
Not applicable
4,016
Ansan, Anyang, Busan, Changwon, Cheongju-si, Chuncheon, Daegu, Daejeon
2024-10-04
Recruiting
Seung-Jung Park
Not applicable
960
Seoul, Ansan, Anyang, Bucheon-si, Busan, Changwon, Chuncheon, Daegu
2024-04-25
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
NCT06246123Arthritis, Rheumatoid, Colitis, Ulcerative
Eisai Korea Inc.
Observational
2,040
Cheonan, Chuncheon, Wŏnju, Ansan, Bucheon-si, Goyang-si, Gwangmyeong, Seongnam-si
2024-02-27
Active, closed
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
NCT05995600Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack, Cerebrovascular Disease
DrugWarfarin
Seoul National University Hospital
Phase 4
200
Anyang, Busan, Cheongju-si, Chuncheon, Daegu, Daejeon, Guri-si, Gwangju
2024-02-20
Recruiting
Samsung Medical Center
Not applicable
2,000
Bucheon-si, Chuncheon, Chungju, Daegu, Daejeon, Gwangju, Gwangmyeong, Ilsan
2023-10-02
Not yet open
FNB in ACL Recon Under GA
NCT06048848Anterior Cruciate Ligament Rupture, Femoral Nerve Block
DrugRopivacaine
Chuncheon Sacred Heart Hospital
Not applicable
100
Chuncheon
2023-09-18
Not yet open
FNB in ACL Recon Under SA
NCT06048874Anterior Cruciate Ligament Rupture, Femoral Nerve Block
DrugRopivacaine
Chuncheon Sacred Heart Hospital
Not applicable
100
Chuncheon
2023-09-18
Recruiting
Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract
NCT06001333Carbapenem-Resistant Enterobacteriaceae, Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)
Chuncheon Sacred Heart Hospital
Not applicable
240
Chuncheon, Seoul
2023-09-18
Active, closed
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Coronary Stenosis
B. Braun Medical Industries Sdn. Bhd.
Not applicable
1,436
Daegu, Chuncheon, Donggu, Ansan-si, Goyang-si, Changwon, Seoul
2023-09-07
Active, closed
Brii Biosciences Limited
Phase 2
86
Chuncheon, Busan, Daegu, Seoul, Soeul
2023-08-22
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Anyang-si, Busan, Cheonan-si, Cheongju-si, Chuncheon, Daegu, Daejeon, Goyang-si
2023-04-11
Recruiting
Seoul National University Hospital
Phase 4
11,086
Seoul, Andong, Busan, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu
2023-03-22
By invitation
Seung-Whan Lee, M.D., Ph.D.
Phase 4
4,000
Bucheon-si, Changwon, Cheonju, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2023-03-14
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Seongnam-si, Gwangju, Seoul, Chuncheon, Incheon, Cheonan, Daegu, Guri-si
2022-12-23
Recruiting
Asan Medical Center
Phase 4
3,944
Bucheon-si, Busan, Changwon, Chuncheon, Chungju, Daegu, Daejeon, Gangneung
2022-10-21
Active, closed
Yonsei University
Observational
260
Busan, Chuncheon, Ansan-si, Goyang-si, Yongin-si, Daegu, Yangsan, Jeonju
2022-08-31
Active, closed
Yuhan Corporation
Observational
2,001
Chilgok, Chuncheon, Wŏnju, Bucheon-si, Uijeongbu-si, Iksan, Seoul, Busan
2022-06-24
Recruiting
Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients
NCT06141798Age Problem, Dialysis; Complications, Frailty, Quality of Life
Soonchunhyang University Hospital
Not applicable
428
Bucheon-si, Chuncheon, Seoul, Wŏnju
2021-11-23
Recruiting
Pharmicell Co., Ltd.
Observational
100
Ansan, Bucheon-si, Cheonan, Chuncheon, Gangneung-si, Seoul, Wŏnju, Yongin
2021-09-09
Recruiting
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
NCT04416581Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction
Duk-Woo Park, MD
Phase 4
3,320
Anyang, Bucheon-si, Busan, Changwon, Cheonan, Cheonju, Chuncheon, Daegu
2021-05-12
Recruiting
Pharmicell Co., Ltd.
Phase 3
200
Ansan, Bucheon-si, Cheonan, Chuncheon, Gangneung-si, Seoul, Wŏnju, Yongin
2021-04-19
Recruiting
Guerbet
Phase 4
2,076
Chuncheon, Gwangju, Seongnam-si, Busan, Seoul
2021-03-24
Recruiting
Duk-Woo Park, MD
Observational
2,000
Chuncheon, Daegu, Daejeon, Gangneung, Kwangju, Pusan, Seoul, Suncheon
2020-09-17
Recruiting
Asan Medical Center
Observational
3,000
Bucheon-si, Busan, Changwon, Chuncheon, Daegu, Daejeon, Gangneung, Jeonju
2020-02-20
Recruiting
National Cancer Center, Korea
Phase 3
1,700
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul
2020-02-15
Active, closed
Seung-Jung Park
Observational
2,000
Busan, Chuncheon, Daegu, Gangneung, Seoul, Suncheon, Wŏnju
2019-12-23
Recruiting
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
NCT03929887Glomerular Disease, Minimal Change Disease, IgA Nephropathy, Membranous Nephropathy
Seoul National University Hospital
Observational
3,000
Chuncheon, Daegu, Seoul
2019-05-01
Recruiting
Seung-Whan Lee, M.D., Ph.D.
Observational
4,000
Anyang, Bucheon-si, Changwon, Cheongju-si, Chuncheon, Daegu, Daejeon, Gangneung
2018-01-11
Active, closed
Kyung Hee University Hospital at Gangdong
Phase 3
358
Busan, Cheonan, Chuncheon, Daegu, Daejeon, Hwasun, Iksan, Seoul
2016-12-07
Active, closed
IRIS-Synergy Cohort in the IRIS-DES Registry
NCT02720419Coronary Artery Disease
Jung-min Ahn
Observational
3,000
Bucheon-si, Busan, Cheonan, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2016-08
Active, closed
IRIS-Onyx Cohort in the IRIS-DES Registry
NCT02593994Coronary Artery Disease, Arterial Occlusive Diseases, Cardiovascular Diseases, Percutaneous Transluminal Angioplasty
Seung-Jung Park
Observational
4,500
Seoul, Anyang, Bucheon-si, Cheonan, Chuncheon, Daegu, Daejeon, Gangneung
2015-10
Recruiting
Young-Hak Kim, MD, PhD
Not applicable
1,000
Seoul, Anyang, Chuncheon, Daegu, Pusan
2014-08-12
Active, closed
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
NCT02112214Gastric Cancer, Helicobacter Pylori Infection
National Cancer Center, Korea
Phase 3
5,224
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul, Uijeongbu-si
2014-06
Recruiting
Gangwon PCI Prospective Registry
NCT02038127Coronary Artery Disease, Ischemic Heart Disease (IHD), Unstable Angina (UA), Non-ST Elevated Myocardial Infarction
Yonsei University
Observational
10,000
Chuncheon, Gangneung, Wŏnju
2013-01-01
Recruiting
Seung-Jung Park
Observational
20,000
Anyang, Bucheon-si, Cheongju-si, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2011-06
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/chuncheon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Chuncheon.

How many clinical trials are recruiting in Chuncheon?

30 of the 50 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 6 have not yet opened recruitment, 12 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chuncheon), 50 studies
PhaseStudiesRecruitingShare
Not applicable17934%
Observational151030%
Phase 38416%
Phase 48616%
Phase 2214%

Most active sponsors

Lead sponsors with the most studies (Chuncheon)
Lead sponsorStudiesRecruiting
Chuncheon Sacred Heart Hospital62
Seoul National University Hospital53
Seung-Jung Park53
Asan Medical Center22
AstraZeneca22
Duk-Woo Park, MD22
Jung-min Ahn21
National Cancer Center, Korea21
Pharmicell Co., Ltd.22
Seung-Whan Lee, M.D., Ph.D.21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.